Results 141 to 150 of about 13,315 (175)

Bedaquiline resistance-associated genetic mutations and minimum inhibitory concentrations in drug-resistant tuberculosis clinical isolates from Limpopo province, South Africa. [PDF]

Front Microbiol
Malope P, Lekalakala-Mokaba MR, Ngcamu DC, Said H, Rukasha I, Omar SV.   +5 more
europepmc   +1 more source

Differences in pulmonary cavity features among drug-sensitive pulmonary tuberculosis and multidrug/extensively-resistant pulmonary tuberculosis: a multi-national multi-center computed tomography-based study. [PDF]

J Thorac Dis
Tang SN, Huang XL, Skrahina A, Zheng QT, Tarasau A, Klimuk D, Alexandru S, Crudu V, Harris M, Hurt DE, Akhundova I, Avaliani Z, Vashakidze S, Shubladze N, Zheng GP, Bao XH, Muntean AA, Strambu I, Zaharia DC, Ghita E, Bogdan M, Munteanu R, Spinu V, Cristea A, Ene C, Kirichenko V, Snezhko E, Kovalev V, Tuzikov A, Gabrielian A, Rosenthal A, Lu PX, Skrahin A, Wáng YXJ.   +33 more
europepmc   +1 more source

Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control.

Releve epidemiologique hebdomadaire, 2006
openaire   +1 more source

Emergence of Extensively Drug-Resistant Shigellosis - United States, 2011-2023.

MMWR Morb Mortal Wkly Rep
Logan N, Birhane MG, McDonald SL, Alarcón J, Amador S, Anand M, Bachmann LH, Bernard K, Black LS, Chen AN, Cooley LA, Fortes ED, Gerard M, Jervis RH, Kimura AC, Lamba K, Latash J, Li L, Pederson G, Kauffman CP, Reynolds JL, Santiago R, Siemetzki-Kapoor U, Smole SC, Tagg KA, Vostok J, Webb HE, Francois Watkins LK, XDR Shigella Working Group.   +28 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Resistance to nitrofurantoin is an indicator of extensive drug-resistant (XDR) Enterobacteriaceae

Journal of Medical Microbiology, 2021
Introduction. Nitrofurantoin is one of the preferred antibiotics in the treatment of uropathogenic multidrug-resistant (MDR) infections. However, resistance to nitrofurantoin in extensively drug-resistant (XDR) bacteria has severely limited the treatment options. Gap statement. Information related to
Balaram Khamari, Prakash Kumar, Bulagonda Eswarappa Pradeep   +2 more
openaire   +2 more sources

Extensively Drug-resistant Tuberculosis (XDR-TB)-inhibitors to Overcome the Scourge of Drug-resistant Tuberculosis: a Perspective

Reviews and Advances in Chemistry, 2020
TB is the 9th leading cause of death worldwide above HIV/AIDS. Tuberculosis (TB) management remains challenging due to the emergence of drug-resistant tuberculosis such as MDR-TB and XDR-TB. To improvise therapeutic results for MDR/XDR-TB, 89 nations had started utilizing bedaquiline and 54 had utilized delamanid by June 2017.
Harun Patel, Iqrar Ahmad, Harsha Jadhav, Rahul Pawara, Anand Mundada, Matin Shaikh, Sanjay Surana   +6 more
openaire   +1 more source

Accompanying therapy of patients with extensive drug-resistant (xdr) lung tuberculosis

Tuberculosis, 2018
Treatment of patients with XDR TB is difficult due to frequent development of adverse reactions. The aim of the study is to assess the tolerability of the V chemotherapy regimen (CR) including Bedaquiline (Sirturo®) in patients with pulmonary TB with XDR in the prescription of cytoflavin (Cytoflavin®) as maintenance therapy.
Ludmila Shovkun, Dmitry Kudlay, Nikolay Nikolenko, Irina Franchuk   +3 more
openaire   +1 more source

The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010

10.2 Tuberculosis, 2015
Introduction: XDR-TB is widely considered a serious threat to global TB control. Despite efforts during the past decade, the XDR-TB incidence rate reaches high values in many countries. In Romania the XDR-TB prevalence rate among MDR-TB patients was 5.4% in 2010.
Ramona Elena Nedelcu, Gilda Popescu, Victor Spinu, Cristina Popa   +3 more
openaire   +1 more source